Skip to main content

ORIGINAL RESEARCH article

Front. Public Health

Sec. Public Health Policy

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1547106

Global, Regional, and National Burden of Liver Cancer in Adolescents and Young Adults from 1990 to 2021: an analysis of the Global Burden of Disease Study 2021 and forecast to 2040

Provisionally accepted
Jingyu Wen Jingyu Wen 1*Mingge Xia Mingge Xia 2Han Luo Han Luo 3Luwei Zhu Luwei Zhu 1Min Li Min Li 1Yifu Hou Yifu Hou 1*
  • 1 Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China
  • 2 University of Macau, Taipa, Macau Region, China
  • 3 Zigong Fourth People's Hospital, Zigong, Sichuan, China

The final, formatted version of the article will be published soon.

    The global burden of liver cancer among adolescents and young adults (AYAs) has often been underestimated, despite significant shifts in its etiology. This study analyzes the disease burden of liver cancer in AYAs from 1990 to 2021 and forecasts trends up to 2040 using data from the Global Burden of Disease Study 2021.Our goal is to provide insights that can inform resource allocation and policy planning.2 Methods: Incidence, mortality, and disability-adjusted life years (DALYs) data were extracted and estimated annual percentage changes calculated to assess trends.Correlation between age-standardized rates and sociodemographic index (SDI) was analyzed using Spearman correlation, and future trends were predicted using the Bayesian age-period-cohort model.Findings: Globally, there were 24,348 new liver cancer cases and 19,270 deaths among AYAs in 2021, with decreases in age-standardized rates for incidence, mortality, and DALYs from 1990 to 2021. East Asia bears the highest burden, with males experiencing significantly higher rates than females. The burden increases with age, peaking at 35-39 years. Higher SDI is associated with lower incidence, mortality, and DALYs. While HBV remains the leading cause, NASH is the fastest-growing contributor to liver cancer incidence and mortality. Projections indicate a continued decline in liver cancer burden among AYAs, though female cases are expected to rise.Interpretation: Despite a gradual decline in liver cancer burden among AYAs, NASH is emerging as a significant and rising cause of incidence and mortality.Regional and gender disparities persist, highlighting the need for tailored prevention and healthcare strategies to alleviate the liver cancer AYA's burden globally.

    Keywords: Global Burden of Disease study, Adolescents and young adults, liver cancer, NASH, Predict

    Received: 17 Dec 2024; Accepted: 17 Feb 2025.

    Copyright: © 2025 Wen, Xia, Luo, Zhu, Li and Hou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Jingyu Wen, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China
    Yifu Hou, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more